Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 4:15 pm Sale |
2024-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
MSD Partners L.P. | 0 0.000% |
-101,010 (Position Closed) |
Filing History |
| 2024-11-14 4:06 pm Purchase |
2024-09-30 | 13G | Alaunos Therapeutics, Inc. TCRT |
MSD Partners L.P. | 101,010 6.300% |
101,010 (New Position) |
Filing History |
| 2024-02-14 12:43 pm Purchase |
2023-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
Discovery Capital Management, LLC | 400,186 1.660% |
292,279 (+270.86%) |
Filing History |
| 2024-02-13 4:58 pm Purchase |
2023-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
MSD Partners L.P. | 2,272,727 9.200% |
2,272,727 (New Position) |
Filing History |
| 2023-02-14 1:30 pm Unchanged |
2022-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
MSD Partners L.P. | 101,010 7.000% |
0 (Unchanged) |
Filing History |
| 2023-02-14 1:18 pm Purchase |
2022-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
Discovery Capital Management, LLC | 107,907 6.730% |
18,930 (+21.28%) |
Filing History |
| 2023-02-09 10:54 am Sale |
2022-12-30 | 13G | Alaunos Therapeutics, Inc. TCRT |
The Vanguard Group | 60,985 3.810% |
-16,573 (-21.37%) |
Filing History |
| 2023-01-20 09:02 am Sale |
2022-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
STATE STREET CORP STT |
5,214 0.330% |
-83,578 (-94.13%) |
Filing History |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Alaunos Therapeutics, Inc. TCRT |
BLACKROCK INC BLK |
34,919 2.400% |
-76,848 (-68.76%) |
Filing History |
| 2022-02-14 5:06 pm Purchase |
2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
Discovery Capital Management, LLC | 88,977 6.170% |
15,678 (+21.39%) |
Filing History |
| 2022-02-11 2:57 pm Purchase |
2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
STATE STREET CORP STT |
88,792 6.160% |
88,792 (New Position) |
Filing History |
| 2022-02-11 12:56 pm Sale |
2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
Hardie Robert D. | 68,446 4.800% |
-1,682 (-2.40%) |
Filing History |
| 2022-02-10 08:47 am Sale |
2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
The Vanguard Group | 77,558 5.380% |
-28,905 (-27.15%) |
Filing History |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
BLACKROCK INC BLK |
111,766 7.800% |
-11,969 (-9.67%) |
Filing History |
| 2021-10-12 1:40 pm Sale |
2021-09-30 | 13G | Alaunos Therapeutics, Inc. TCRT |
LMM LLC | 25,253 1.730% |
-83,108 (-76.70%) |
Filing History |
| 2021-02-16 1:10 pm Purchase |
2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
Hardie Robert D. | 70,128 4.900% |
1,254 (+1.82%) |
Filing History |
| 2021-02-16 10:05 am Sale |
2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
LMM LLC | 108,361 7.450% |
-1,787 (-1.62%) |
Filing History |
| 2021-02-10 12:04 pm Purchase |
2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
The Vanguard Group | 106,463 7.450% |
22,496 (+26.79%) |
Filing History |
| 2021-02-01 08:23 am Purchase |
2020-12-31 | 13G | Alaunos Therapeutics, Inc. TCRT |
BLACKROCK INC BLK |
123,736 8.700% |
40,457 (+48.58%) |
Filing History |
| 2021-01-07 4:21 pm Purchase |
2020-12-28 | 13G | Alaunos Therapeutics, Inc. TCRT |
Discovery Capital Management, LLC | 73,298 5.130% |
73,298 (New Position) |
Filing History |